跳至主要内容
临床试验/IRCT201503163320N10
IRCT201503163320N10已完成未知

The effect of a single dose of vitamin D3 injection on serum 25 hydroxy vitamin D and adiponectin and liver function in women with non-alcoholic fatty liver disease

Vice Chancellor for research of Tabriz University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
Female

入选标准

  • willingness to participate in the study, 18-50 years old, liver steatosis on sonographic image, vitamin D deficiency(25(OH)D levels less than 30ng/ml), BMI=25
  • Exclusion criteria: Alcohol consumption(more than 20g/day), menopause, gestation or lactation, BMI>40, diabetes and insulin resistance, any other liver disease(viral disease, Wilson, Hemochromatosis, glycogen storage disorders and etc) or using drugs for the treatment of fatty liver(such as omega-3 and herbal supplements), Thyroid and parathyroid disorders, bone problems, Cushing's syndrome, fat malabsorption, cholecystectomy and any other disease that affect the liver, renal disease(renal failure and nephrolithiasis), using vitamin D, calcium and vitamin E supplements in the past 6 months, taking any drugs causing fatty liver or hepatotoxic drugs(calcium channel blocker,methotrexate,tamoxifen, valproate, diltiazem, amiodarone, isoniazid, corticosteroids and high-dose of estrogen and progestin, and the use of contraceptives), taking drugs affecting insulin resistance and liver function(Such as metformin, pioglitazone, lovastatin and etc.), get weight loss diet in the past 6 months, using total parenteral nutrition in the past 6 months.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Tabriz University of Medical Sciences

相似试验

vitamin D and non-alcoholic fatty liver disease | 临床试验